Nisa Investment Advisors
COLL icon

Nisa Investment Advisors’s Collegium Pharmaceutical COLL Stock Holding History

Nisa Investment Advisors’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$80.9K Buy
2,234
+135
+6% +$4.61K ﹤0.01% 1648
2026
Q1 		$69.4K Sell
2,099
-1
-0% -$42 ﹤0.01% 1551
2025
Q4 		$97.2K Sell
2,100
-169
-7% -$7.07K ﹤0.01% 1445
2025
Q3 		$79.4K Buy
2,269
+34
+2% +$1.18K ﹤0.01% 1502
2025
Q2 		$66.1K Buy
2,235
+45
+2% +$1.28K ﹤0.01% 1521
2025
Q1 		$65.4K Sell
2,190
-303
-12% -$9.26K ﹤0.01% 1512
2024
Q4 		$71.4K Buy
2,493
+316
+15% +$10.5K ﹤0.01% 1570
2024
Q3 		$84.1K Buy
2,177
+19
+0.9% +$678 ﹤0.01% 1493
2024
Q2 		$69.5K Buy
2,158
+24
+1% +$832 ﹤0.01% 1565
2024
Q1 		$82.8K Buy
2,134
+31
+1% +$1.08K ﹤0.01% 1522
2023
Q4 		$64.7K Hold
2,103
– – ﹤0.01% 1566
2023
Q3 		$47K Hold
2,103
– – ﹤0.01% 1742
2023
Q2 		$45.2K Hold
2,103
– – ﹤0.01% 1782
2023
Q1 		$50K Sell
2,103
-320
-13% -$8.49K ﹤0.01% 1716
2022
Q4 		$56K Hold
2,423
– – ﹤0.01% 1732
2022
Q3 		$43K Buy
2,423
+33
+1% +$582 ﹤0.01% 1794
2022
Q2 		$42K Buy
2,390
+1,950
+443% +$32.8K ﹤0.01% 1787
2022
Q1 		$9K Sell
440
-4,359
-91% -$82.4K ﹤0.01% 2225
2021
Q4 		$86K Sell
4,799
-3,156
-40% -$61.5K ﹤0.01% 1572
2021
Q3 		$157K Buy
7,955
+7,335
+1,183% +$159K ﹤0.01% 1503
2021
Q2 		$15K Hold
620
– – ﹤0.01% 2172
2021
Q1 		$15K Hold
620
– – ﹤0.01% 2161
2020
Q4 		$12K Sell
620
-2,492
-80% -$48.7K ﹤0.01% 2187
2020
Q3 		$65K Buy
3,112
+2,392
+332% +$43.2K ﹤0.01% 1696
2020
Q2 		$13K Sell
720
-145
-17% -$2.84K ﹤0.01% 1860
2020
Q1 		$14K Hold
865
– – ﹤0.01% 1783
2019
Q4 		$18K Sell
865
-7,655
-90% -$128K ﹤0.01% 1710
2019
Q3 		$98K Buy
+8,520
New +$97.3K ﹤0.01% 1461

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Nisa Investment Advisors's COLL Position: Q2 2026 in Review

Nisa Investment Advisors increased its Collegium Pharmaceutical (COLL) stake by 6.4% in Q2 2026, buying an estimated $4.61K and bringing the position to 2,234 shares worth $80.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1648.

Nisa Investment Advisors first reported a position in COLL in Q3 2019 and has held it in 28 quarters since. The position peaked at $157K in Q3 2021. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Nisa Investment Advisors held 2,234 shares of Collegium Pharmaceutical worth $80.9K as of Q2 2026.
  • Nisa Investment Advisors bought 135 Collegium Pharmaceutical shares in Q2 2026, an estimated $4.61K.
  • Collegium Pharmaceutical made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1648 holding.
  • Nisa Investment Advisors first reported a position in Collegium Pharmaceutical in Q3 2019 and has held it in 28 quarters since.
  • Nisa Investment Advisors's Collegium Pharmaceutical position peaked at $157K in Q3 2021.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.